STACIE ROSE: Open Payments
NPI 1871194381 · LEXINGTON, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 10 payments from 6 companies in 2025. Trend: 2023 $1,279 · 2024 $864 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 4 | $112 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Otsuka America Pharmaceutical, Inc. | 2 | $34 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Lundbeck LLC | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $21 |
Products named: COBENFY, REXULTI, Auvelity, INVEGA SUSTENNA, AUSTEDO XR.
Industry payments across MA — which companies pay providers there.
